Pharmacoeconomic analysis of enzalutamide and abiraterone for treatment of chemotherapy naive patients with metastatic castration resistant prostate cancer

N. A. Avxentyev; M. Yu. Frolov; A. S. Makarov

Cancer Urology
Onkourologiâ

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

User

eng | рус

Cancer Urology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Avxentyev N.A., Frolov M.Yu., Makarov A.S. Pharmacoeconomic analysis of enzalutamide and abiraterone for treatment of chemotherapy naive patients with metastatic castration resistant prostate cancer. Cancer Urology. 2017;13(3):76-86. (In Russ.) https://doi.org/10.17650/1726-9776-2017-13-3-76-86

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Boris Ya. Alekseev

About the Authors

N. A. Avxentyev
Research Institute of Finance Institute of Social Analysis and Prognosis, Russian Presidential Academy of National Economy and Public Administration
Russian Federation

Build 2, 3 Nastas’inskiy Pereulok, Moscow 127006, Russia

Build. 1, 82 Vernadskogo Prospekt, Moscow 119571, Russia

M. Yu. Frolov
Volgograd State Medical University, Ministry of Health of Russia Association of Clinical Pharmacologists
Russian Federation

1 Pavshikh Bortsov Ploshchad’, Volgograd 400131, Russia

A. S. Makarov
Association of Clinical Pharmacologists
Russian Federation

1 Pavshikh Bortsov Ploshchad’, Volgograd 400131, Russia

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cancer Urology

For citations:

Cookies policy